Articles tagged with Neuromuscular Diseases
Researchers at Stanford Medicine have discovered a small molecule that restores lost connections between nerves and muscle fibers in aging mice, leading to improved strength and function. The study suggests that the drug may one day be used to prevent or treat muscle loss due to aging or disease.
A new national ALS research consortium, Access for All in ALS, has been launched with a $16.7 million NIH award. The consortium will include 34 clinical sites nationwide and generate a longitudinal biorepository linked to detailed clinical information.
The August issue of CHEST journal features a new clinical practice guideline for managing patients with neuromuscular weakness and a multisociety evidence review on the effect of race and ethnicity on pulmonary function testing interpretation. This is complemented by other research and reviews covering various aspects of chest medicine.
Researchers at Tokyo Metropolitan University have discovered that 5-aminolevulinic acid can selectively boost Complex II and IV to counteract Complex I deficiency, a common cause of mitochondrial disorders. This finding offers new hope for the development of treatments for debilitating conditions such as MELAS syndrome.
A recent study in Columbus reveals striking disparities in accessibility for wheelchair users traveling by public bus. Manual wheelchair users have access to only 1% of the city, while powered wheelchair users can reach about 25%. The main obstacle is infrastructure, particularly sidewalks, which are damaged or missing in many areas.
The American College of Chest Physicians released a clinical practice guideline on respiratory management for patients with neuromuscular weakness, providing evidence-based recommendations for mouthpiece ventilation and airway clearance therapies. The guideline aims to improve care for this vulnerable population.
A study published in Journal of Neuromuscular Diseases demonstrates a positive effect of nusinersen treatment on motor function in ambulant pediatric and adult SMA patients. Clinically meaningful improvements in walking distance were observed in a subgroup of patients, with only five adult walkers showing a decline.
Researchers developed an iEMG classifier framework for detecting myopathy and neuropathy, achieving high accuracy in three muscle types and low computational time. The study showed promise for real-time implementation, aiding clinicians in making quick and accurate diagnoses.
A new study found that children with four copies of the SMN2 gene who received pre-symptomatic treatment showed no symptoms, while untreated patients developed irreversible symptoms. The researchers recommend encouraging early intervention in childhood for these patients to avoid potential deficits.
Researchers have discovered that mutations causing Duchenne muscular dystrophy slow electrical activity in the heart, leading to abnormal heart rhythms. This finding may help explain why up to 60% of DMD patients experience life-threatening heart rhythm abnormalities and could lead to new treatment strategies.
Researchers from the University of Tsukuba found that Synapsology, a game-like dual-task exercise, helps maintain or improve cognitive and physical abilities in older adults aged 85-97. The study, published in Alzheimer's & Dementia, suggests that this cost-effective intervention can have a societal impact.
A new study found that patients with spinal muscular atrophy (SMA) who were identified through newborn screening had lower financial costs compared to those identified after symptoms arose. Early treatment also resulted in reduced costs, highlighting the importance of timely intervention.
Scientists discover that activating TAK1 in skeletal muscle promotes muscle growth and prevents atrophy, with implications for treating conditions like cancer, COPD, and genetic diseases. The research also highlights the importance of maintaining healthy neuromuscular junctions.
Researchers uncover the pleiotropic functions of hnRNPK in regulating skeletal muscle cell differentiation, including inhibition of myoblast differentiation and suppression of genes involved in endoplasmic reticulum stress. The study suggests that targeting hnRNPK could be a potential therapeutic strategy for treating human disorders.
A study by Harvard T.H. Chan School of Public Health researchers found a strong association between Epstein-Barr virus infection and multiple sclerosis. The risk of MS increased 32-fold after EBV infection, while serum levels of neurofilament light chain, a biomarker of nerve degeneration, only increased after EBV infection.
A study by GIST scientists found that physical interaction between children with cerebral palsy and horses improves motor skills and balance. The research team recorded horse and child movements, tracking acceleration and angular velocity to quantify interactions, which were linked to improved outcomes.
Researchers highlight the importance of sharing well-conducted studies with negative or irreproducible results, even if they disprove a hypothesis. The Journal of Neuromuscular Diseases special issue on 'The Null Hypothesis' presents eight articles that contribute valuable information to the scientific record.
Researchers developed a wearable, biocompatible, and low-cost biosensor that measures electromyography signals in muscles. The sensor uses a gold-silver nanocomposite printed onto fabric, providing a comfortable and effective way to track muscle activity.
A study published in the Journal of Neuromuscular Diseases found Nusinersen treatment improved motor and respiratory functions in adults with longstanding SMA3. Functional testing showed significant improvements on the 6-Minute-Walk-Test, with patients experiencing a mean improvement of 8.25 meters.
A new position paper published in the Journal of Neuromuscular Diseases emphasizes the importance of patient-centered approach in neuromuscular disease research. The paper advocates for shared decision-making and patient involvement in research activities, including clinical trials, biobanks, and regulatory processes.
Researchers at Karolinska Institutet have discovered a new way in which nerve cells control movement by dynamically adjusting neurotransmitter production. This finding opens up new avenues for treating diseases such as myasthenia gravis and spinal muscular atrophy.
A new study published in the New England Journal of Medicine found that Spinraza significantly improves outcomes for children with spinal muscular atrophy type 2, who have not yet begun to walk. The drug also shows promise for reversing muscle weakness and improving mobility.
Scientists uncover fragile alliance between SMN protein and Gemins that leads to SMA. Disrupting this balance causes catastrophic consequences, including death in flies and muscle weakness.
Researchers have discovered a plant-based compound that targets the root cause of spinal muscular atrophy (SMA), a genetic disorder causing muscle wastage and weakness in infants. Quercetin has shown promise in tests on zebra fish, mice, and fruit flies, offering a potential treatment option for early stages of the disease.
Researchers have discovered a plant pigment called quercetin that targets the mutated gene causing spinal muscular atrophy (SMA), a leading genetic cause of death in children. Quercetin has been shown to improve nerve and muscle cell health in tests on zebra fish, mice, and fruit flies.
Research identifies pivotal role of proteins in cellular and disease processes, shedding light on neuromuscular disorder and cancer connections. The study found that impaired Mpc1 and Mpc2 lead to deadly health problems, including the neuromuscular disorder.
A study found that invasive treatment strategies, including heart testing and pacemaker implantation, can increase survival rates for patients with myotonic dystrophy type 1. The treatment approach resulted in a lower incidence of sudden death and improved overall survival.
Researchers quantified needle grasp by measuring pullout force, finding that two types of needle rotation had greater effects than no manipulation. These findings suggest a potential role for manual needle manipulation in acupuncture therapy.